SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-15-035660
Filing Date
2015-02-05
Accepted
2015-02-05 17:23:15
Documents
17

Document Format Files

Seq Description Document Type Size
1 424B4 d775834d424b4.htm 424B4 1838438
2 GRAPHIC g775834g09s01.jpg GRAPHIC 19616
3 GRAPHIC g775834g13f41.jpg GRAPHIC 36562
4 GRAPHIC g775834g22l21.jpg GRAPHIC 296233
5 GRAPHIC g775834g29h51.jpg GRAPHIC 34874
6 GRAPHIC g775834g35r45.jpg GRAPHIC 11347
7 GRAPHIC g775834g42e62.jpg GRAPHIC 14160
8 GRAPHIC g775834g43y20.jpg GRAPHIC 52636
9 GRAPHIC g775834g54d78.jpg GRAPHIC 16320
10 GRAPHIC g775834g58s37.jpg GRAPHIC 33520
11 GRAPHIC g775834g66l16.jpg GRAPHIC 52186
12 GRAPHIC g775834g67f83.jpg GRAPHIC 44119
13 GRAPHIC g775834g70f03.jpg GRAPHIC 124899
14 GRAPHIC g775834g70w35.jpg GRAPHIC 38428
15 GRAPHIC g775834g79i74.jpg GRAPHIC 11505
16 GRAPHIC g775834g87n54.jpg GRAPHIC 26815
17 GRAPHIC g775834ibc.jpg GRAPHIC 390090
  Complete submission text file 0001193125-15-035660.txt   3499901
Mailing Address NATL INST FOR BIOPROCESSING RESEARCH FOSTERS AVENUE, MOUNT MERRION BLACKROCK CO. DUBLIN L2 00000
Business Address NATL INST FOR BIOPROCESSING RESEARCH FOSTERS AVENUE, MOUNT MERRION BLACKROCK CO. DUBLIN L2 00000 353 1 215 8100
Nexvet Biopharma plc (Filer) CIK: 0001618561 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 0630
Type: 424B4 | Act: 33 | File No.: 333-201309 | Film No.: 15581192
SIC: 2834 Pharmaceutical Preparations